Deployment of Artificial Intelligence, Biosensors, and Imaging Technologies to Drive Transformational Growth
Comprehensive wound assessment is vital to understand the nature of wounds and devise evidence-based and cost-effective therapeutic interventions. However, traditionally used methods for wound diagnosis and monitoring cannot accurately measure wound dimensions, require physical contact with the wound, which causes discomfort to the patients, and can be time-consuming. This study highlights the challenges of traditional wound diagnosis and monitoring methods and examines the innovations that can address these limitations.
Wound diagnosis and monitoring devices that are powered by advanced technologies (such as multispectral imaging, hyperspectral imaging, fluorescence imaging, biocapacitance, thermal imaging, biosensors, and artificial intelligence) can improve the quality of care delivery and enhance the clinical decision-making process. The report examines the new solutions in the wound diagnosis and monitoring industry, including digital wound assessment tools, hand-held scanners, and other products, such as skin patches, portable screening devices, mattresses, and insoles. It also covers some of the path-breaking innovators in this space and notes their technology-readiness levels. The study investigates notable government and private funding, partnership, and acquisition activities and discusses the growth opportunities offered by wound diagnosis and monitoring technologies. It also highlights the key patents filed by technology developers in the last three years. The scope of this study is global.
Table of Contents
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Adiuvo Diagnostics Pvt Ltd
- Bluedrop Medical Limited
- European Commission
- Grapheal SAS, France
- Healthy.io Ltd.
- MolecuLight Inc.
- National Institutes of Health (NIH)
- Swift Medical Inc.